FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

708825002: Oteracil (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2015. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3036894016 Oteracil en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3037430011 Oxonic acid en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3037632014 Oteracil (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
829891000172111 otéracil fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oteracil Is a Monocarboxylate (substance) true Inferred relationship Some
Oteracil Is a Triazine derivative (substance) true Inferred relationship Some
Oteracil Is a Orotate phosphoribosyltransferase inhibitor true Inferred relationship Some
Oteracil This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Orotate phosphoribosyltransferase inhibitor true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Oteracil potassium This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Oteracil Inferred relationship Some
Gimeracil 4.35 mg and oteracil (as oteracil potassium) 11.8 mg and tegafur 15 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Oteracil Inferred relationship Some 2
Product containing only gimeracil and oteracil and tegafur (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Oteracil Inferred relationship Some 2
Product containing gimeracil and oteracil and tegafur (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Oteracil Inferred relationship Some 2
Gimeracil and oteracil and tegafur only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Oteracil Inferred relationship Some 2
Gimeracil- and oteracil- and tegafur-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Oteracil Inferred relationship Some 2
Product containing precisely gimeracil 5.8 milligram and oteracil (as oteracil potassium) 15.8 milligram and tegafur 20 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Oteracil Inferred relationship Some 2

This concept is not in any reference sets

Back to Start